Healthcare / Medical DevicesUpdated 2026-05-10 22:07 UTC

ASX/ARX stock hub

ASX/ARX has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

ASX/ARXis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

221.4M

Australian Securities Exchange

Market data

Live price

Current market quote for this ticker.

Current price

ASX/ARX

In the news

Latest news · ASX/ARX

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E41.4

P25 12.9P50 20.4P75 41.2

Trailing P/En/a

P25 14.2P50 19.2P75 35.1

ROE-2

P25 -118.7P50 -49.4P75 -1.2

ROIC0.4

P25 -74.7P50 -33.5P75 0.1

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All ASX/ARX market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

187

Groups with data

Currency

NZD

Showing 187 of 187 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	New Zealand
Country code	AU
Employees	110
Enterprise value	AUD 206.8M
Exchange	Australian Securities Exchange
Financial currency	NZD
First seen	2026-05-10
Industry	Medical Devices
Isin	NZARXE0001S1
Last refreshed	2026-05-10
Market cap	AUD 221.4M
Price	AUD 0.64
Price currency	AUD
Sector	Healthcare
Sic	2836
Symbol	asx/ARX
Website	https://aroa.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-0.72%
EV Earnings	-129.6x
EV/EBITDA	46.89x
EV/FCF	46.79x
EV/Sales	2.61x
FCF yield	2%
Forward P/E	41.39x
P/B ratio	2.73x
P/S ratio	2.79x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	0.7%
EBITDA Margin	4.23%
FCF margin	5.58%
Gross margin	85.07%
Gross Profit	AUD 67.4M
Gross Profit Growth	5.91%
Gross Profit Growth Q	12.62%
Gross Profit Growth3 Y	9.25%
Gross Profit Growth5 Y	7.54%
Net Income	AUD -1.6M
Net Income Growth Years	1%
Pretax Margin	-1.53%
Profit Margin	-2.01%
ROA	0.37
Roa5y	-4.82
ROCE	0.64
ROE	-1.97
Roe5y	-16.78
ROIC	0.4

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	48.88%
Cagr3y	-15.21%
Cagr5y	-11.06%
EPS Growth Years	1
Revenue Growth	18.4x
Revenue Growth Q	14.57x
Revenue Growth Quarters	5x
Revenue Growth Years	4x
Revenue Growth3 Y	9.39x
Revenue Growth5 Y	7.37x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	AUD 0.84
Assets	AUD 95.3M
Cash	AUD 20.7M
Current Assets	AUD 56M
Current Liabilities	AUD 8.6M
Debt	AUD 6.1M
Debt EBITDA	AUD 1.39
Debt Equity	AUD 0.08
Debt FCF	AUD 1.39
Equity	AUD 81M
Interest Coverage	1.45
Liabilities	AUD 14.4M
Long Term Assets	AUD 39.4M
Long Term Liabilities	AUD 5.8M
Net Cash	AUD 14.6M
Net Cash By Market Cap	AUD 6.58
Net Cash Growth	10.75%
Net Debt EBITDA	AUD -4.35
Net Debt Equity	AUD -0.18
Net Debt FCF	AUD -3.3
Tangible Book Value	AUD 68.7M
Tangible Book Value Per Share	AUD 0.2
WACC	8.68

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	6.52
Inventory Turnover	1.56
Net Working Capital	AUD 30.9M
Quick ratio	5.6
Working Capital	AUD 50.5M
Working Capital Turnover	AUD 1.39

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.19%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	48.84%
200-day SMA	0.66
3Y total return	-39.05%
50-day SMA	0.58
50-day SMA vs 200-day SMA	50under200
5Y total return	-44.35%
All Time High	1.75
All Time High Change	-63.32%
All Time High Date	2020-07-30
All Time Low	0.35
All Time Low Change	82.86%
All Time Low Date	2025-04-07
ATR	0.04
Beta	0.82
Beta1y	0.38
Beta2y	0.34
Ch YTD	-13.51
High	0.68
High52	0.8
High52 Date	2025-11-05
High52ch	-20%
Low	0.63
Low52	0.43
Low52 Date	2025-05-21
Low52ch	49.88%
Ma50ch	10.12%
Price vs 200-day SMA	-3.15%
RSI	62.19
RSI Monthly	48.63
RSI Weekly	51.36
Sharpe ratio	0.89x
Sortino ratio	1.56
Total Return	-0.19%
Tr YTD	-13.51
Tr1m	16.36%
Tr1w	3.23%
Tr3m	-1.54%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	AUD 552,332
Operating margin	0.7

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	259,006,119%
Net Borrowing	-1,001,494.8
Shares Insiders	25.12%
Shares Institutions	32.32%
Shares Out	345,902,653
Shares Qo Q	-0.08%
Shares Yo Y	0.19%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	AUD 2.5M
Average Volume	234,132.75x
Bv Per Share	0.23
CAPEX	AUD -1.1M
Ch1m	16.36
Ch1w	3.23
Ch1y	48.84
Ch3m	-1.54
Ch3y	-39.05
Ch5y	-44.35
Ch6m	-16.88
Change	-0.78%
Change From Open	-4.48
Close	0.65
Days Gap	3.88
Depreciation Amortization	2,625,117.7
Dollar Volume	119,881
Earnings Date	2026-05-26
EBIT	AUD 552,332
EBITDA	AUD 3.3M
EPS	AUD -0
F Score	4
FCF	AUD 4.4M
FCF EV Yield	2.14x
FCF Per Share	AUD 0.01
Financing CF	-1,444,831
Fiscal Year End	March
Founded	2,007
Goodwill	4,557,336
Income Tax	AUD 385,756
Investing CF	-7,085,634
Is Primary Listing	1
Last Earnings Date	2026-01-27
Last Report Date	2025-09-30
Ma150	0.66
Ma150ch	-3.74%
Ma20	0.56
Ma20ch	13.41%
Net CF	-2,763,415
Next Earnings Date	2026-05-26
Open	0.67
P FCF Ratio	50.09
P OCF Ratio	40.2
Position In Range	22.22
Ppne	17,868,904.8
Price Date	2026-05-08
Price EBITDA	AUD 66.1
Ptbv Ratio	3.22
Relative Volume	0.81x
Revenue	79,256,174x
SBC By Revenue	2.39x
Share Based Comp	1,893,711
Tax By Revenue	0.49x
Tr6m	-16.88%
Volume	187,314
Z Score	8.68

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does ASX/ARX pay a dividend?

Capital-return profile for this ticker.

Performance

ASX/ARX stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns ASX/ARX?

Insider, institutional, and short-interest positioning.

Institutional ownership

+32.3%

Share of float held by funds and institutions

Insider ownership

+25.1%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.2%

Negative means the company is buying back shares.

Technical

ASX/ARX momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

62.2

Neutral momentum band

Price vs 200-day MA

-3.1%

50/200-day relationship not available

Beta (5Y)

0.82

Moves roughly with the market

Sharpe ratio

0.89

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About ASX/ARX

Hub-level FAQ points readers to the deeper analysis pages.

What is the current asx/ARX stock rating?

asx/ARX is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full asx/ARX analysis?

The full report lives at /stocks/asx/ARX/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for asx/ARX?

The latest report frames asx/ARX around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the asx/ARX page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.